Brain TfR levels were decreased in mice treated with TfR:BACE1, in contrast to an increasing trend of brain TfR levels when treated with biMOG Low :TfR:SarsCov (Fig. 9 C).
← all excerpts
Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein.
1
—
—